出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2023年7月
癒着防止材市場 : 製品 (再生セルロース、ヒアルロン酸、PEG)、タイプ (フィルム、ジェル、液体)、処置 (腹部、心臓血管、婦人科、神経科)、エンドユーザー (病院、診療所、ASC)、地域別 – 2028年までの世界予測
Adhesion Barrier Market by Product (Regenerated Cellulose, Hyaluronic Acid, PEG), Type (Film, Gel, Liquid), Procedure (Abdominal, Cardiovascular, Gynae, Neurology), End User (Hospitals, Clinics & ASC), Region – Global Forecast to 2028
| ページ数 | 231 |
| 図表数 | 257 |
| 種別 | 英文調査報告書 |
| 価格 |
The adhesion barriers market is valued at an estimated USD 0.7 billion in 2023 and is projected to reach USD 0.9 baillion by 2028, at a CAGR of 7.4% during the forecast period. The main drivers promoting the development of this market are the rising number of surgeries and sports-related injuries, an increasing elderly population, and the rising awareness of adhesion formation and diseases associated with adhesions.
“The synthetic adhesion barrier market is projected to witness the highest growth in the adhesion barriers market, by type of products, during the forecast period.”
Based on products, the adhesion barriers market is further segmented into synthetic and natural adhesion barriers. Synthetic adhesion barriers are further classified into hyaluronic acid, regenerated cellulose, polyethylene glycol, and other synthetic adhesion barriers. the hyaluronic acid based adhesion barriers segment accounted for the largest share of the synthetic adhesion barrier market, owing to their properties of biocompatibility and bioresorbable.
“General/Abdominal Surgeries is the largest application segment of the adhesion barrier market.”
In 2022, based on applications, General/Abdominal Surgeries held the largest share of the adhesion barriers market. The large share of this segment can be attributed to factors such as the higher risk of post-surgical adhesion formation in General/Abdominal Surgeries, the growing volume of General/Abdominal Surgeries, and the availability of several commercialized adhesion barrier products for General/Abdominal Surgeries.
“Asia Pacific market to witness the highest growth during the forecast period”
On the basis of region, the adhesion barriers market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Adhesion barrier market is expected to grow in the APAC due to factors such as steadily increasing geriatric population, the epidemiological shift from infectious to chronic diseases, and rising medical tourism. As a result, the APAC is anticipated to grow faster than other regions during the forecast period with the highest CAGR.
A breakdown of the primary participants (supply-side) for the adhesion barrier market referred to for this report is provided below:
a
• By Company Type: Tier 1: 42%, Tier 2: 35%, and Tier 3: 23%
• By Designation: C-level Executives: 28%, Directors: 35%, and Others: 37%
• By Region: North America: 33%, Europe: 24%, Asia Pacific: 18%, Latin America: 10%; Middle East: 10%; Africa: 5%
The prominent players operating in the adhesion barriers market are Baxter International (US), Johnson & Johnson (J&J) (US), and Becton, Dickinson and Company (US), Integra LifeSciences (US), Anika Therapeutics (US), Atrium Medical Corporation (US), FzioMed (US), MAST Biosurgery (Switzerland), Innocoll (Ireland), Betatech Medical (Turkey), CorMatrix Cardiovascular, Inc. (US), Terumo Corporation (Japan), BiosCompass (US), W.L.Gore & Associates (US), GUNZE Limited (Japan), Leader Biomedical (Netherlands), Xlynk Surgical (US), Luna Solutions (US), PlantTec Medical GmbH (Germany), Actamax Surgical Materials, LLC (US), Arc Medical Devices, INC. (US), CG Bio INC. (Korea), Seikagaku Corporation (Japan), Hangzhou Singclean Medical Products Co.,Ltd (China)and Allosource (US).
Research Coverage:
The market study covers the adhesion barrier market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by product, by formulation, by application, by end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall adhesion barrier market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
• Analysis of key drivers (Rising geriatric population, Increase in the volume of surgeries and sports-related injuries, Increasing awareness about the medical implications of adhesions), restraints (Reluctance of surgeons to use adhesion barriers, Product recalls), opportunities (Untapped emerging markets) and challenges (Stringent regulations resulting in limited technological innovations) influencing the growth of the adhesion barrier market
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global adhesion barrier market. The report analyzes this market by type of product , formulation, application, and region.
• Product Enhancement/Innovation: Detailed insights on upcoming trends and service launches in the global adhesion barrier market.
• Market Development: Comprehensive information on the lucrative emerging markets by type of product , formulation, application, and region.
• Market Diversification: Exhaustive information about new products and services, growing geographies, recent developments, and investments in the global adhesion barrier market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product and service offerings, and capabilities of leading players in the global adhesion barrier market.
目次
1 INTRODUCTION 31
1.1 STUDY OBJECTIVES 31
1.2 MARKET DEFINITION 32
1.2.1 PRODUCT 32
1.2.2 FORMULATION 32
1.3 INCLUSIONS AND EXCLUSIONS 33
1.3.1 MARKETS COVERED 34
1.3.2 YEARS CONSIDERED 34
1.4 CURRENCY CONSIDERED 35
TABLE 1 STANDARD CURRENCY CONVERSION RATES 35
1.5 STAKEHOLDERS 35
1.6 SUMMARY OF CHANGES 35
1.6.1 RECESSION IMPACT: ADHESION BARRIER MARKET 36
2 RESEARCH METHODOLOGY 37
2.1 RESEARCH DATA 37
FIGURE 1 RESEARCH DESIGN 37
2.1.1 SECONDARY DATA 37
2.1.1.1 Key data from secondary sources 39
2.1.2 PRIMARY DATA 39
FIGURE 2 PRIMARY SOURCES 40
2.1.2.1 Key data from primary sources 41
2.1.2.2 Key industry insights 42
FIGURE 3 PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 42
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY-SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 43
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND-SIDE): BY END USER, DESIGNATION, AND REGION 43
2.2 MARKET SIZE ESTIMATION 44
FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 44
FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: BAXTER INTERNATIONAL 45
FIGURE 8 SUPPLY-SIDE ANALYSIS: ADHESION BARRIER MARKET 46
FIGURE 9 TOP-DOWN APPROACH 47
FIGURE 10 BOTTOM-UP APPROACH 47
FIGURE 11 US: ORTHOPEDIC SURGERIES APPROACH 48
FIGURE 12 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR ADHESION BARRIER MARKET (2023–2028) 49
FIGURE 13 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 50
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 51
FIGURE 14 DATA TRIANGULATION METHODOLOGY 51
2.4 MARKET SHARE ESTIMATION 51
2.5 STUDY ASSUMPTIONS 52
2.6 RESEARCH LIMITATIONS 52
2.6.1 SCOPE-RELATED LIMITATIONS 52
2.6.2 METHODOLOGY-RELATED LIMITATIONS 53
2.7 RISK ASSESSMENT 53
TABLE 2 RISK ASSESSMENT: ADHESION BARRIER MARKET 53
2.8 IMPACT OF RECESSION ON ADHESION BARRIER MARKET 53
3 EXECUTIVE SUMMARY 54
FIGURE 15 ADHESION BARRIER MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 54
FIGURE 16 ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2023 VS. 2028 (USD MILLION) 55
FIGURE 17 ADHESION BARRIER MARKET, BY FORMULATION, 2023 VS. 2028 (USD MILLION) 55
FIGURE 18 ADHESION BARRIER MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 56
FIGURE 19 ADHESION BARRIER MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 57
FIGURE 20 GEOGRAPHICAL SNAPSHOT OF ADHESION BARRIER MARKET 57
4 PREMIUM INSIGHTS 59
4.1 ADHESION BARRIER MARKET OVERVIEW 59
FIGURE 21 INCREASING VOLUME OF SURGERIES RISING GERIATRIC POPULATION TO DRIVE MARKET 59
4.2 ASIA PACIFIC: ADHESION BARRIER MARKET, BY PRODUCT AND COUNTRY (2022) 60
FIGURE 22 SYNTHETIC BARRIERS ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC ADHESION BARRIER MARKET IN 2022 60
4.3 ADHESION BARRIER MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 61
FIGURE 23 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 61
4.4 REGIONAL MIX: ADHESION BARRIER MARKET (2023−2028) 61
FIGURE 24 NORTH AMERICA TO DOMINATE ADHESION BARRIER MARKET IN 2028 61
4.5 ADHESION BARRIER MARKET: EMERGING VS. DEVELOPED ECONOMIES 62
FIGURE 25 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD 62
5 MARKET OVERVIEW 63
5.1 INTRODUCTION 63
5.2 MARKET DYNAMICS: ADHESION BARRIER MARKET 63
5.2.1 DRIVERS 63
5.2.1.1 Rapid growth in geriatric population globally 63
TABLE 3 GROWTH RATE IN GERIATRIC POPULATION, BY REGION, 2020–2050 64
TABLE 4 LIST OF COMMON SPECIALTIES AND PROCEDURES IN OLDER ADULTS 64
5.2.1.2 Increase in volume of surgeries and sports-related injuries 65
TABLE 5 US: PERCENTAGE INCREASE IN NUMBER OF SURGICAL PROCEDURES PERFORMED (2010 VS. 2020) 65
5.2.1.3 Increasing awareness about medical implications of adhesions 65
5.2.2 RESTRAINTS 66
5.2.2.1 Reluctance of surgeons to use adhesion barriers 66
5.2.3 OPPORTUNITIES 66
5.2.3.1 Untapped markets in emerging economies 66
5.2.4 CHALLENGES 67
5.2.4.1 Stringent regulations and limited technological innovations 67
5.3 INDUSTRY TRENDS 67
5.3.1 RISING FOCUS ON GEL FORM OF ADHESION BARRIERS FOR SURGERIES 67
TABLE 6 AVERAGE ADHESION FORMATION RATE IN LAPAROSCOPIC SURGERIES 67
5.4 REGULATORY ANALYSIS 68
5.4.1 NORTH AMERICA 68
5.4.1.1 US 68
TABLE 7 CLASSIFICATION OF MEDICAL DEVICES BY US FDA 68
FIGURE 26 PREMARKET NOTIFICATION: 510(K) APPROVAL FOR MEDICAL DEVICES 69
5.4.1.2 Canada 69
FIGURE 27 APPROVAL PROCESS FOR CLASS III MEDICAL DEVICES IN CANADA 70
5.4.2 EUROPE 70
FIGURE 28 CE APPROVAL PROCESS IN EUROPE FOR BIOSURGERY PRODUCTS 70
5.4.3 ASIA PACIFIC 71
5.4.3.1 Japan 71
TABLE 8 CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODY IN JAPAN 71
5.4.3.2 China 71
TABLE 9 NMPA MEDICAL DEVICE CLASSIFICATION 72
5.4.3.3 India 72
5.5 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73
TABLE 10 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73
TABLE 11 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73
TABLE 12 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
5.6 VALUE CHAIN ANALYSIS 75
FIGURE 29 VALUE CHAIN ANALYSIS: MAXIMUM VALUE ADDED DURING COMPONENT AND PRODUCT MANUFACTURING PHASE 76
5.7 SUPPLY CHAIN ANALYSIS 76
FIGURE 30 ADHESION BARRIER MARKET: SUPPLY CHAIN ANALYSIS 77
5.8 ECOSYSTEM MAPPING 78
FIGURE 31 ADHESION BARRIER MARKET: ECOSYSTEM MAPPING 78
5.9 PORTER’S FIVE FORCES ANALYSIS 79
TABLE 13 PORTER’S FIVE FORCES ANALYSIS 79
5.9.1 THREAT OF NEW ENTRANTS 79
5.9.2 THREAT OF SUBSTITUTES 80
5.9.3 BARGAINING POWER OF SUPPLIERS 80
5.9.4 BARGAINING POWER OF BUYERS 80
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 80
5.10 PATENT ANALYSIS 81
5.10.1 PATENT PUBLICATION TRENDS FOR ADHESION BARRIERS 81
FIGURE 32 ADHESION BARRIER MARKET: GLOBAL PATENT PUBLICATION TRENDS (2015–2023) 81
5.10.2 ADHESION BARRIER MARKET: TOP APPLICANTS 82
FIGURE 33 TOP APPLICANTS FOR ADHESION BARRIER PATENTS (2015–2023) 82
5.10.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS 82
FIGURE 34 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR ADHESION BARRIER PATENTS (2015–2023) 82
5.11 TECHNOLOGY ANALYSIS 83
TABLE 14 ANTI-ADHESION BARRIERS AS SUBJECT OF RECENT RESEARCH 83
5.12 PRICING ANALYSIS 84
TABLE 15 AVERAGE SELLING PRICE OF ADHESION BARRIER PRODUCTS OFFERED BY KEY PLAYERS 84
5.13 KEY CONFERENCES AND EVENTS (2023–2025) 84
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 85
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 85
FIGURE 35 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR ADHESION BARRIER PRODUCTS 85
TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR ADHESION BARRIER PRODUCTS 85
5.14.2 BUYING CRITERIA 86
FIGURE 36 KEY BUYING CRITERIA FOR ADHESION BARRIER PRODUCTS 86
TABLE 17 KEY BUYING CRITERIA FOR ADHESION BARRIER PRODUCTS 86
6 ADHESION BARRIER MARKET, BY PRODUCT 87
6.1 INTRODUCTION 88
TABLE 18 ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 88
6.2 SYNTHETIC ADHESION BARRIERS 88
TABLE 19 KEY BRANDS OF SYNTHETIC ADHESION BARRIERS 88
TABLE 20 ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 89
TABLE 21 ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY COUNTRY, 2021–2028 (USD MILLION) 90
6.2.1 HYALURONIC ACID 90
6.2.1.1 Greater biocompatibility and higher bioresorbability to drive segment 90
TABLE 22 HYALURONIC ACID MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 91
6.2.2 REGENERATED CELLULOSE 91
6.2.2.1 Non-reactive and bacteriostatic nature of regenerated cellulose to drive use in gynecological surgeries 91
TABLE 23 REGENERATED CELLULOSE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 92
6.2.3 POLYETHYLENE GLYCOL 92
6.2.3.1 Ability to decrease post-surgical adhesions after abdominal and peritoneal surgeries to drive segment 92
TABLE 24 POLYETHYLENE GLYCOL MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 93
6.2.4 OTHER SYNTHETIC ADHESION BARRIERS 93
TABLE 25 OTHER SYNTHETIC ADHESION BARRIERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 94
6.3 NATURAL ADHESION BARRIERS 94
6.3.1 TIME-CONSUMING AND COMPLEX APPLICATIONS DURING SURGERIES TO LIMIT MARKET 94
TABLE 26 LIST OF NATURAL ADHESION BARRIERS AVAILABLE 95
TABLE 27 ADHESION BARRIER MARKET FOR NATURAL ADHESION BARRIERS, BY COUNTRY, 2021–2028 (USD MILLION) 95
7 ADHESION BARRIER MARKET, BY FORMULATION 96
7.1 INTRODUCTION 97
TABLE 28 ADOPTION OF DIFFERENT ADHESION BARRIER FORMULATIONS IN SURGERIES 97
TABLE 29 ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 97
7.2 FILM FORMULATIONS 98
7.2.1 FILM FORMULATIONS DOMINATED ADHESION BARRIER MARKET IN 2022 98
TABLE 30 INDICATIVE LIST OF COMMERCIALLY AVAILABLE ADHESION BARRIERS WITH FILM FORMULATIONS 98
TABLE 31 ADHESION BARRIER MARKET FOR FILM FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 99
7.3 GEL FORMULATIONS 99
7.3.1 HIGHER PREFERENCE FOR GEL-BASED FORMULATIONS OVER FILM-BASED BARRIERS TO DRIVE MARKET 99
TABLE 32 INDICATIVE LIST OF COMMERCIALLY AVAILABLE ADHESION BARRIERS WITH GEL FORMULATIONS 100
TABLE 33 ADHESION BARRIER MARKET FOR GEL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 101
7.4 LIQUID FORMULATIONS 101
7.4.1 LIQUID FORMULATIONS TO BE WIDELY USED IN GYNECOLOGICAL, PELVIC, AND ABDOMINAL SURGERIES 101
TABLE 34 INDICATIVE LIST OF COMMERCIALLY AVAILABLE ADHESION BARRIERS WITH LIQUID FORMULATIONS 102
TABLE 35 ADHESION BARRIER MARKET FOR LIQUID FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 102
8 ADHESION BARRIER MARKET, BY APPLICATION 103
8.1 INTRODUCTION 104
TABLE 36 ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 104
8.2 GENERAL/ABDOMINAL SURGERIES 104
8.2.1 INCREASING FORMATION OF POST-OPERATIVE ADHESIONS AND RISING COMPLICATIONS AMONG PATIENTS TO DRIVE MARKET 104
TABLE 37 ADHESION BARRIER MARKET FOR GENERAL/ABDOMINAL SURGERIES, BY COUNTRY, 2021–2028 (USD MILLION) 105
8.3 GYNECOLOGICAL SURGERIES 105
8.3.1 RISING INCIDENCE OF PELVIC AND UTERINE CANCER AND INCREASING NUMBER OF C-SECTIONS TO DRIVE MARKET 105
TABLE 38 PREVALENCE OF INTRAUTERINE ADHESIONS ACROSS DIFFERENT GYNECOLOGICAL PROCEDURES (IN %) 106
TABLE 39 COUNTRIES WITH HIGHEST C-SECTION RATES (2022) 106
TABLE 40 ADHESION BARRIER MARKET FOR GYNECOLOGICAL SURGERIES, BY COUNTRY, 2021–2028 (USD MILLION) 107
8.4 CARDIOVASCULAR SURGERIES 108
8.4.1 INCREASING NUMBER OF POST-OPERATIVE COMPLICATIONS TO DRIVE MARKET 108
TABLE 41 INDICATIVE LIST OF COMMERCIALLY AVAILABLE ADHESION BARRIERS FOR CARDIOVASCULAR SURGICAL APPLICATIONS 108
TABLE 42 ADHESION BARRIER MARKET FOR CARDIOVASCULAR SURGERIES, BY COUNTRY, 2021–2028 (USD MILLION) 109
8.5 ORTHOPEDIC SURGERIES 109
8.5.1 GROWING NUMBER OF SPORT-RELATED INJURIES TO DRIVE MARKET 109
TABLE 43 ADHESION BARRIER MARKET FOR ORTHOPEDIC SURGERIES, BY COUNTRY, 2021–2028 (USD MILLION) 110
8.6 NEUROLOGICAL SURGERIES 110
8.6.1 GROWING CONCERNS ABOUT PHYSICAL PAIN AND IMPAIRMENT AFTER NEUROLOGICAL SURGERIES TO DRIVE MARKET 110
TABLE 44 ADHESION BARRIER MARKET FOR NEUROLOGICAL SURGERIES, BY COUNTRY, 2021–2028 (USD MILLION) 111
8.7 RECONSTRUCTIVE SURGERIES 111
8.7.1 HIGHER INSURANCE COVERAGE FOR COSMETIC SURGERIES TO DRIVE MARKET 111
TABLE 45 ADHESION BARRIER MARKET FOR RECONSTRUCTIVE SURGERIES, BY COUNTRY, 2021–2028 (USD MILLION) 112
8.8 UROLOGICAL SURGERIES 112
8.8.1 GROWING INCIDENCE OF POST-OPERATIVE ADHESION FORMATION TO DRIVE MARKET 112
TABLE 46 ADHESION BARRIER MARKET FOR UROLOGICAL SURGERIES, BY COUNTRY, 2021–2028 (USD MILLION) 113
8.9 OTHER SURGERIES 113
TABLE 47 ADHESION BARRIER MARKET FOR OTHER SURGERIES, BY COUNTRY, 2021–2028 (USD MILLION) 114
9 ADHESION BARRIER MARKET, BY END USER 115
9.1 INTRODUCTION 116
TABLE 48 ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 116
9.2 HOSPITALS AND CLINICS 116
9.2.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES AND RISING ADOPTION OF SAFETY MEASURES TO DRIVE MARKET 116
TABLE 49 ADHESION BARRIER MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021–2028 (USD MILLION) 117
9.3 AMBULATORY SURGICAL CENTERS 117
9.3.1 INCREASING NUMBER OF OUTPATIENT VISITS AND FAVORABLE REIMBURSEMENT POLICIES TO DRIVE MARKET 117
TABLE 50 ADHESION BARRIER MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 118
9.4 OTHER END USERS 119
TABLE 51 ADHESION BARRIER MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 119
10 ADHESION BARRIER MARKET, BY REGION 120
10.1 INTRODUCTION 121
TABLE 52 ADHESION BARRIER MARKET, BY REGION, 2021–2028 (USD MILLION) 121
10.2 NORTH AMERICA 122
TABLE 53 US: ARTHROPLASTY PROCEDURAL VOLUME, BY YEAR (N = 1,787,914) 122
10.2.1 NORTH AMERICA: RECESSION IMPACT 122
TABLE 54 NORTH AMERICA: HEALTHCARE EXPENDITURE, BY COUNTRY (USD BILLION) 122
FIGURE 37 NORTH AMERICA: ADHESION BARRIER MARKET SNAPSHOT 123
TABLE 55 NORTH AMERICA: ADHESION BARRIER MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 56 NORTH AMERICA: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 124
TABLE 57 NORTH AMERICA: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 124
TABLE 58 NORTH AMERICA: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 124
TABLE 59 NORTH AMERICA: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 125
TABLE 60 NORTH AMERICA: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 125
10.2.2 US 125
10.2.2.1 US dominated North American adhesion barrier market in 2022 125
FIGURE 38 GERIATRIC POPULATION IN US (65 YEARS AND ABOVE IN MILLION) 126
TABLE 61 US: KEY MACROINDICATORS 127
TABLE 62 US: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 127
TABLE 63 US: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 127
TABLE 64 US: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 128
TABLE 65 US: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 128
TABLE 66 US: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 128
10.2.3 CANADA 129
10.2.3.1 Increasing number of C-section surgeries to drive market 129
TABLE 67 CANADA: KEY MACROINDICATORS 129
TABLE 68 CANADA: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 130
TABLE 69 CANADA: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 130
TABLE 70 CANADA: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 130
TABLE 71 CANADA: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 131
TABLE 72 CANADA: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 131
10.3 EUROPE 132
TABLE 73 EUROPEAN COUNTRIES WITH HIGHEST C-SECTION RATE (2021) 132
10.3.1 EUROPE: RECESSION IMPACT 132
TABLE 74 EUROPE: ADHESION BARRIER MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 133
TABLE 75 EUROPE: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 133
TABLE 76 EUROPE: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 133
TABLE 77 EUROPE: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 134
TABLE 78 EUROPE: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 134
TABLE 79 EUROPE: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 134
10.3.2 GERMANY 135
10.3.2.1 Germany accounted for largest share of European adhesion barrier market in 2022 135
TABLE 80 GERMANY: KEY MACROINDICATORS 135
TABLE 81 GERMANY: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 135
TABLE 82 GERMANY: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 136
TABLE 83 GERMANY: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 136
TABLE 84 GERMANY: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 137
TABLE 85 GERMANY: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 137
10.3.3 FRANCE 137
10.3.3.1 Rising number of advanced orthopedic surgeries to drive market 137
TABLE 86 FRANCE: KEY MACROINDICATORS 138
TABLE 87 FRANCE: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 138
TABLE 88 FRANCE: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 138
TABLE 89 FRANCE: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 139
TABLE 90 FRANCE: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 139
TABLE 91 FRANCE: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 139
10.3.4 UK 140
10.3.4.1 Rising number of cardiovascular, gynecological, and orthopedic surgeries to drive market 140
TABLE 92 UK: PERCENTAGE SHARE OF AGING POPULATION (2019–2036) 140
TABLE 93 UK: KEY MACROINDICATORS 141
TABLE 94 UK: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 141
TABLE 95 UK: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 141
TABLE 96 UK: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 142
TABLE 97 UK: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 142
TABLE 98 UK: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 142
10.3.5 ITALY 143
10.3.5.1 Rising geriatric population and increasing prevalence of chronic diseases to drive market 143
TABLE 99 ITALY: KEY MACROINDICATORS 143
TABLE 100 ITALY: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 144
TABLE 101 ITALY: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 144
TABLE 102 ITALY: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 144
TABLE 103 ITALY: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 145
TABLE 104 ITALY: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 145
10.3.6 SPAIN 145
10.3.6.1 High cost of surgical procedures to limit market 145
TABLE 105 SPAIN: KEY MACROINDICATORS 146
TABLE 106 SPAIN: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 146
TABLE 107 SPAIN: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 147
TABLE 108 SPAIN: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 147
TABLE 109 SPAIN: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 148
TABLE 110 SPAIN: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 148
10.3.7 REST OF EUROPE 148
TABLE 111 REST OF EUROPE: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 149
TABLE 112 REST OF EUROPE: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 149
TABLE 113 REST OF EUROPE: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 150
TABLE 114 REST OF EUROPE: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 150
TABLE 115 REST OF EUROPE: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 151
10.4 ASIA PACIFIC 151
FIGURE 39 ASIA PACIFIC: ADHESION BARRIER MARKET SNAPSHOT 152
10.4.1 ASIA PACIFIC: RECESSION IMPACT 152
TABLE 116 ASIA PACIFIC: ADHESION BARRIER MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 153
TABLE 117 ASIA PACIFIC: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 153
TABLE 118 ASIA PACIFIC: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 153
TABLE 119 ASIA PACIFIC: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 154
TABLE 120 ASIA PACIFIC: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 154
TABLE 121 ASIA PACIFIC: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 155
10.4.2 JAPAN 155
10.4.2.1 Rising geriatric population and increasing number of surgical procedures performed to drive market 155
TABLE 122 JAPAN: KEY MACROINDICATORS 156
TABLE 123 JAPAN: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 156
TABLE 124 JAPAN: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 156
TABLE 125 JAPAN: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 157
TABLE 126 JAPAN: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 157
TABLE 127 JAPAN: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 157
10.4.3 CHINA 158
10.4.3.1 Rapid economic growth and increasing disposable income of middle-class population to drive market 158
TABLE 128 CHINA: KEY MACROINDICATORS 158
TABLE 129 CHINA: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 159
TABLE 130 CHINA: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 159
TABLE 131 CHINA: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 159
TABLE 132 CHINA: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 160
TABLE 133 CHINA: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 160
10.4.4 INDIA 160
10.4.4.1 Rising focus of multinational companies and improving urban healthcare infrastructure to drive market 160
TABLE 134 INDIA: KEY MACROINDICATORS 161
TABLE 135 INDIA: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 161
TABLE 136 INDIA: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 162
TABLE 137 INDIA: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 162
TABLE 138 INDIA: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 163
TABLE 139 INDIA: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 163
10.4.5 AUSTRALIA 163
10.4.5.1 Growing government awareness campaigns and rising funding and grants for medical research to drive market 163
TABLE 140 AUSTRALIA: KEY MACROINDICATORS 164
TABLE 141 AUSTRALIA: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 164
TABLE 142 AUSTRALIA: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 143 AUSTRALIA: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 165
TABLE 144 AUSTRALIA: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 165
TABLE 145 AUSTRALIA: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 165
10.4.6 SOUTH KOREA 166
10.4.6.1 Growing geriatric population and increasing disposable incomes to drive market 166
TABLE 146 SOUTH KOREA: KEY MACROINDICATORS 166
TABLE 147 SOUTH KOREA: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 166
TABLE 148 SOUTH KOREA: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 167
TABLE 149 SOUTH KOREA: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 167
TABLE 150 SOUTH KOREA: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 168
TABLE 151 SOUTH KOREA: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 168
10.4.7 REST OF ASIA PACIFIC 168
TABLE 152 NEW ZEALAND: REGISTERED JOINT ARTHROPLASTIES CONDUCTED FROM 2015–2021 169
TABLE 153 REST OF ASIA PACIFIC: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 169
TABLE 154 REST OF ASIA PACIFIC: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 169
TABLE 155 REST OF ASIA PACIFIC: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 170
TABLE 156 REST OF ASIA PACIFIC: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 170
TABLE 157 REST OF ASIA PACIFIC: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 171
10.5 LATIN AMERICA 171
10.5.1 LATIN AMERICA: RECESSION IMPACT 171
TABLE 158 LATIN AMERICA: ADHESION BARRIER MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 172
TABLE 159 LATIN AMERICA: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 172
TABLE 160 LATIN AMERICA: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 161 LATIN AMERICA: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 173
TABLE 162 LATIN AMERICA: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 173
TABLE 163 LATIN AMERICA: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 174
10.5.2 BRAZIL 174
10.5.2.1 Brazil to command largest market share for adhesion barriers in Latin America 174
TABLE 164 BRAZIL: KEY MACROINDICATORS 174
TABLE 165 BRAZIL: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 175
TABLE 166 BRAZIL: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 167 BRAZIL: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 175
TABLE 168 BRAZIL: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 176
TABLE 169 BRAZIL: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 176
10.5.3 MEXICO 176
10.5.3.1 Rising burden of chronic diseases and well-organized healthcare system to drive market 176
TABLE 170 MEXICO: KEY MACROINDICATORS 177
TABLE 171 MEXICO: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 177
TABLE 172 MEXICO: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 178
TABLE 173 MEXICO: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 178
TABLE 174 MEXICO: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 179
TABLE 175 MEXICO: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 179
10.5.4 REST OF LATIN AMERICA 179
TABLE 176 REST OF LATIN AMERICA: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 180
TABLE 177 REST OF LATIN AMERICA: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 178 REST OF LATIN AMERICA: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 180
TABLE 179 REST OF LATIN AMERICA: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 181
TABLE 180 REST OF LATIN AMERICA: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 181
10.6 MIDDLE EAST & AFRICA 182
10.6.1 INCREASING NUMBER OF GYNECOLOGICAL AND GENERAL SURGERIES TO DRIVE MARKET 182
10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 182
TABLE 181 MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 183
TABLE 182 MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET FOR SYNTHETIC ADHESION BARRIERS, BY TYPE, 2021–2028 (USD MILLION) 183
TABLE 183 MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET, BY FORMULATION, 2021–2028 (USD MILLION) 183
TABLE 184 MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 184
TABLE 185 MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET, BY END USER, 2021–2028 (USD MILLION) 184
11 COMPETITIVE LANDSCAPE 185
11.1 OVERVIEW 185
11.2 KEY STRATEGIES ADOPTED BY MAJOR PLAYERS IN ADHESION BARRIER MARKET (JANUARY 2020– JULY 2023) 185
11.3 REVENUE SHARE ANALYSIS OF KEY PLAYERS 186
FIGURE 40 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN ADHESION BARRIER MARKET (2018–2022) 186
11.4 MARKET SHARE ANALYSIS 187
FIGURE 41 ADHESION BARRIER MARKET SHARE, BY KEY PLAYER, 2022 187
11.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS 188
11.5.1 STARS 188
11.5.2 EMERGING LEADERS 189
11.5.3 PERVASIVE PLAYERS 189
11.5.4 PARTICIPANTS 189
FIGURE 42 ADHESION BARRIER MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022 190
11.6 COMPANY EVALUATION MATRIX FOR START-UPS/SMES 191
11.6.1 PROGRESSIVE COMPANIES 191
11.6.2 DYNAMIC COMPANIES 191
11.6.3 STARTING BLOCKS 191
11.6.4 RESPONSIVE COMPANIES 191
FIGURE 43 ADHESION BARRIER MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022) 192
11.7 COMPETITIVE BENCHMARKING 193
TABLE 186 PRODUCT PORTFOLIO ANALYSIS: ADHESION BARRIER MARKET 193
TABLE 187 FORMULATION PORTFOLIO ANALYSIS: ADHESION BARRIER MARKET 194
TABLE 188 APPLICATION PORTFOLIO ANALYSIS: ADHESION BARRIER MARKET 195
TABLE 189 END USER PORTFOLIO ANALYSIS: ADHESION BARRIER MARKET 196
TABLE 190 OVERALL PORTFOLIO ANALYSIS: ADHESION BARRIER MARKET 197
11.8 COMPANY GEOGRAPHICAL FOOTPRINT 198
TABLE 191 REGIONAL REVENUE MIX: ADHESION BARRIER MARKET 198
11.9 COMPETITIVE SITUATION AND TRENDS 199
11.9.1 KEY PRODUCT LAUNCHES AND APPROVALS 199
TABLE 192 KEY PRODUCT LAUNCHES AND APPROVALS 199
11.9.2 KEY ACQUISITIONS 200
12 COMPANY PROFILES 201
12.1 KEY PLAYERS 201
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
12.1.1 BAXTER INTERNATIONAL INC. 201
TABLE 193 BAXTER INTERNATIONAL INC: COMPANY OVERVIEW 201
FIGURE 44 BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT (2022) 202
12.1.2 JOHNSON & JOHNSON 204
TABLE 194 JOHNSON & JOHNSON: COMPANY OVERVIEW 204
FIGURE 45 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2022) 205
12.1.3 BECTON, DICKINSON AND COMPANY 207
TABLE 195 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 207
FIGURE 46 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022) 208
12.1.4 INTEGRA LIFESCIENCES HOLDINGS CORPORATION 210
TABLE 196 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY OVERVIEW 210
FIGURE 47 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT (2022) 211
12.1.5 ANIKA THERAPEUTICS INC. 213
TABLE 197 ANIKA THERAPEUTICS INC.: COMPANY OVERVIEW 213
FIGURE 48 ANIKA THERAPEUTICS INC.: COMPANY SNAPSHOT (2022) 214
12.1.6 ATRIUM MEDICAL CORPORATION 215
TABLE 198 ATRIUM MEDICAL CORPORATION: COMPANY OVERVIEW 215
FIGURE 49 ATRIUM MEDICAL CORPORATION: COMPANY SNAPSHOT (2022) 216
12.1.7 TERUMO CORPORATION 217
TABLE 199 TERUMO CORPORATION: COMPANY OVERVIEW 217
FIGURE 50 TERUMO CORPORATION: COMPANY SNAPSHOT (2022) 218
12.1.8 FZIOMED, INC. 219
TABLE 200 FZIOMED, INC.: COMPANY OVERVIEW 219
12.1.9 MAST BIOSURGERY 220
TABLE 201 MAST BIOSURGERY: COMPANY OVERVIEW 220
12.1.10 INNOCOLL 221
TABLE 202 INNOCOLL: COMPANY OVERVIEW 221
12.1.11 BETATECH MEDICAL 222
TABLE 203 BETATECH MEDICAL: COMPANY OVERVIEW 222
12.1.12 CORMATRIX CARDIOVASCULAR, INC. 223
TABLE 204 CORMATRIX CARDIOVASCULAR, INC.: COMPANY OVERVIEW 223
12.1.13 BIOSCOMPASS, INC. 224
TABLE 205 BIOSCOMPASS, INC.: COMPANY OVERVIEW 224
12.1.14 W.L. GORE & ASSOCIATES, INC. 225
TABLE 206 W. L. GORE & ASSOCIATES, INC.: COMPANY OVERVIEW 225
12.1.15 ALLOSOURCE 226
TABLE 207 ALLOSOURCE: COMPANY OVERVIEW 226
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
12.2 OTHER PLAYERS (ADHESION BARRIER PRODUCTS UNDER DEVELOPMENT) 227
12.2.1 XLYNK SURGICAL 227
12.2.2 LUNA INNOVATIONS 227
12.2.3 ACTAMAX SURGICAL MATERIAL, LLC 227
12.2.4 ARC MEDICAL INC. 228
12.2.5 CG BIO INC. 228
12.2.6 LEADER BIOMEDICAL 228
12.2.7 PLANTTEC MEDICAL GMBH 228
12.2.8 HANGZHOU SINGCLEAN MEDICAL PRODUCTS CO., LTD. 229
12.2.9 SEIKAGAKU CORPORATION 229
12.2.10 GUNZE LIMITED 229
13 APPENDIX 230
13.1 DISCUSSION GUIDE 230
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 235
13.3 CUSTOMIZATION OPTIONS 237
13.4 RELATED REPORTS 237
13.5 AUTHOR DETAILS 238